Hypoxia-induced Maspin Expression Affects the Prognosis of Ovarian Clear Cell Carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun Ji | - |
dc.contributor.author | Park, Soo Jin | - |
dc.contributor.author | Lee, Cheol | - |
dc.contributor.author | Yim, Ga Won | - |
dc.contributor.author | Kim, Jae Weon | - |
dc.contributor.author | Kim, Hee Seung | - |
dc.date.accessioned | 2024-06-13T06:00:31Z | - |
dc.date.available | 2024-06-13T06:00:31Z | - |
dc.date.issued | 2022-01 | - |
dc.identifier.issn | 0258-851X | - |
dc.identifier.issn | 1791-7549 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74154 | - |
dc.description.abstract | Background/Aim: To investigate the role of the expression of hypoxia-related genes on the prognosis of Methods: Basal mRNA levels of eight hypoxia-related genes were compared. Cell viability was assayed after treating ES2 cells under hypoxic conditions. The mRNA and protein levels were evaluated after the induction of hypoxia and administration of increased doses of N-acetylcysteine (NAC). Finally, the prognostic role of their expression levels was evaluated in 61 patients with OCCC. Results: The mRNA and protein levels of maspin increased gradually with the induction of hypoxia. Maspin protein expression decreased after treatment with paclitaxel and NAC. High expression of maspin was related to poor progression-free and overall survival in patients with OCCC (adjusted hazard ratios, 3.97 and 7.47; 95% confidence intervals=1.34-11.81, and 1.9828.13). Conclusion: High expression of maspin induced by hypoxia might be associated with poor prognosis of OCCC. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | INT INST ANTICANCER RESEARCH | - |
dc.title | Hypoxia-induced Maspin Expression Affects the Prognosis of Ovarian Clear Cell Carcinoma | - |
dc.type | Article | - |
dc.identifier.doi | 10.21873/invivo.12693 | - |
dc.identifier.bibliographicCitation | IN VIVO, v.36, no.1, pp 212 - 220 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000740654700004 | - |
dc.identifier.scopusid | 2-s2.0-85123036787 | - |
dc.citation.endPage | 220 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 212 | - |
dc.citation.title | IN VIVO | - |
dc.citation.volume | 36 | - |
dc.type.docType | Article | - |
dc.publisher.location | 그리이스 | - |
dc.subject.keywordAuthor | Clear cell | - |
dc.subject.keywordAuthor | hypoxia | - |
dc.subject.keywordAuthor | maspin | - |
dc.subject.keywordAuthor | ovarian cancer | - |
dc.subject.keywordAuthor | prognosis | - |
dc.subject.keywordPlus | CANCER-CELLS | - |
dc.subject.keywordPlus | ANGIOGENESIS | - |
dc.subject.keywordPlus | STATHMIN | - |
dc.subject.keywordPlus | BIOLOGY | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.